Literature DB >> 19156484

Nosocomial ventriculitis and meningitis in neurocritical care patients.

R Beer1, P Lackner, B Pfausler, E Schmutzhard.   

Abstract

BACKGROUND: External ventricular drainage (EVD) is frequently necessary in neurological and neurosurgical intensive care patients. A major complication of this procedure is an EVD-related venticulitis or meningitis. The purpose of this review is (1) to address the magnitude of the problem in the neurocritical care patient population, (2) to discuss the difficulties in providing an appropriate and timely diagnosis of this disease entity and (3) to propose an algorithm for both rapid diagnosis and appropriate therapy.
METHODS: A MEDLINE literature search was carried out for studies from January 1990 through March 2008 reporting on ventriculostomy, EVD-related central nervous system infections, in particular ventriculitis and meningitis.
RESULTS: EVD-related ventriculitis is a serious nosocomial complication in the neurocritical care setting where EVD catheters are frequently used for the management of elevated ICP secondary to acute hydrocephalus primarily caused by subarachnoid and intraventricular hemorrhage or traumatic brain injury. Infection rate is high with reported incidences in the range of 5 % up to more than 20 %. Predisposing factors for infection are non-adherence to rigid insertion and maintenance protocols, leakage of cerebrospinal fluid (CSF), catheter irrigation and the frequency of EVD manipulation. Diagnosis is frequently impaired either by the presence of systemic inflammation due to the primary disease or because the hemorrhagic CSF itself may cause an inflammatory reaction. Furthermore, the most common pathogens involved in EVD-related infections, i. e., staphylococci, initially provoke only a mild inflammatory response in the CSF and therefore patients rarely present with clear-cut clinical signs indicating severe central nervous system infection, in particular, ventriculitis.
CONCLUSION: Nosocomial EVD-related ventriculitis is a significant cause of morbidity and mortality in critically ill neurological patients. Rapid diagnosis and prompt initiation of appropriate antimicrobial therapy is needed. A stepwise algorithm for the management of EVD-related ventriculitis is proposed.

Entities:  

Mesh:

Year:  2008        PMID: 19156484     DOI: 10.1007/s00415-008-0059-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  43 in total

1.  Ventriculostomy-associated infections: incidence and risk factors.

Authors:  Yaseen Arabi; Ziad A Memish; Hanan H Balkhy; Christine Francis; Ahmad Ferayan; Abdullah Al Shimemeri; Maha A Almuneef
Journal:  Am J Infect Control       Date:  2005-04       Impact factor: 2.918

2.  Lack of value of routine analysis of cerebrospinal fluid for prediction and diagnosis of external drainage-related bacterial meningitis.

Authors:  Rogier P Schade; Janke Schinkel; Freek W C Roelandse; Ronald B Geskus; Leo G Visser; J Marc C van Dijk; Marc C Van Dijk; Joan H C Voormolen; Hans Van Pelt; Ed J Kuijper
Journal:  J Neurosurg       Date:  2006-01       Impact factor: 5.115

3.  Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients.

Authors:  Pavlos Myrianthefs; Sophia L Markantonis; Konstantinos Vlachos; Maria Anagnostaki; Eleni Boutzouka; Dimitris Panidis; Georgios Baltopoulos
Journal:  Antimicrob Agents Chemother       Date:  2006-09-18       Impact factor: 5.191

4.  Ventriculostomy infections: the effect of monitoring duration and catheter exchange in 584 patients.

Authors:  K L Holloway; T Barnes; S Choi; R Bullock; L F Marshall; H M Eisenberg; J A Jane; J D Ward; H F Young; A Marmarou
Journal:  J Neurosurg       Date:  1996-09       Impact factor: 5.115

5.  Central venous catheter-related bacteremia due to gram-negative bacilli: significance of catheter removal in preventing relapse.

Authors:  Hend Hanna; Claude Afif; Badie Alakech; Maha Boktour; Jeffrey Tarrand; Ray Hachem; Issam Raad
Journal:  Infect Control Hosp Epidemiol       Date:  2004-08       Impact factor: 3.254

6.  Intrathecal administration of amikacin for treatment of meningitis secondary to cephalosporin-resistant Escherichia coli.

Authors:  S L Preston; L L Briceland
Journal:  Ann Pharmacother       Date:  1993 Jul-Aug       Impact factor: 3.154

7.  Early diagnosis of external ventricular drainage infection: results of a prospective study.

Authors:  W Pfisterer; M Mühlbauer; T Czech; A Reinprecht
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

8.  Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia.

Authors:  Manuel Iregui; Suzanne Ward; Glenda Sherman; Victoria J Fraser; Marin H Kollef
Journal:  Chest       Date:  2002-07       Impact factor: 9.410

Review 9.  Safety profile of meropenem: an updated review of over 6,000 patients treated with meropenem.

Authors:  Peter Linden
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

10.  Impact of nosocomial infectious complications after subarachnoid hemorrhage.

Authors:  Jennifer A Frontera; Andres Fernandez; J Michael Schmidt; Jan Claassen; Katja E Wartenberg; Neeraj Badjatia; Augusto Parra; E Sander Connolly; Stephan A Mayer
Journal:  Neurosurgery       Date:  2008-01       Impact factor: 4.654

View more
  54 in total

Review 1.  Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Allan R Tunkel; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

Review 2.  External ventricular drainage for intraventricular hemorrhage.

Authors:  Mahua Dey; Jennifer Jaffe; Agnieszka Stadnik; Issam A Awad
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

3.  Population Pharmacokinetics of Combined Intravenous and Local Intrathecal Administration of Meropenem in Aneurysm Patients with Suspected Intracranial Infections After Craniotomy.

Authors:  Xingang Li; Shusen Sun; Qiang Wang; Zhigang Zhao
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-02       Impact factor: 2.441

4.  International and specialty trends in the use of prophylactic antibiotics to prevent infectious complications after insertion of external ventricular drainage devices.

Authors:  Paul J McCarthy; Shashikant Patil; Steven A Conrad; L Keith Scott
Journal:  Neurocrit Care       Date:  2010-04       Impact factor: 3.210

5.  Local complications of adjunct intrathecal antibiotics for nosocomial meningitis associated with gram-negative pathogens: a meta-analysis.

Authors:  Alexandros G Brotis; Isaac Churis; Marios Karvouniaris
Journal:  Neurosurg Rev       Date:  2019-12-24       Impact factor: 3.042

6.  Intraventricular fibrinolysis has no effects on shunt dependency and functional outcome in endovascular-treated aneurysmal SAH.

Authors:  Stefan T Gerner; Joji B Kuramatsu; Henning Abel; Stephan P Kloska; Hannes Lücking; Ilker Y Eyüpoglu; Arnd Doerfler; Stefan Schwab; Hagen B Huttner
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

7.  Reply: PCR assay for pathogen detection in ventriculostomy-related meningitis in neurosurgery patients: unanswered questions?

Authors:  Peter-Michael Rath; Beate Schoch; Michael Adamzik; Eike Steinmann; Jan Buer; Joerg Steinmann
Journal:  Infection       Date:  2015-01-30       Impact factor: 3.553

8.  Early monitoring of ventriculostomy-related infections with procalcitonin in patients with ventricular drains.

Authors:  Amr S Omar; Amr ElShawarby; Rajvir Singh
Journal:  J Clin Monit Comput       Date:  2015-02-01       Impact factor: 2.502

Review 9.  Physiological monitoring of the severe traumatic brain injury patient in the intensive care unit.

Authors:  Peter Le Roux
Journal:  Curr Neurol Neurosci Rep       Date:  2013-03       Impact factor: 5.081

10.  Management of nosocomial external ventricular drain-related ventriculomeningitis.

Authors:  Ronny Beer; Bettina Pfausler; Erich Schmutzhard
Journal:  Neurocrit Care       Date:  2008-11-04       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.